Overview
Jan Nordrehaug practices in Bergen, Norway. Nordrehaug is rated as an Advanced expert by MediFind in the treatment of Heart Attack. Their top areas of expertise are Stable Angina, Heart Attack, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Thrombectomy.
Their clinical research consists of co-authoring 110 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 35 articles in the study of Heart Attack.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AnginaNordrehaug isAdvanced. Learn about Angina.
- Coronary Heart DiseaseNordrehaug isAdvanced. Learn about Coronary Heart Disease.
- Heart AttackNordrehaug isAdvanced. Learn about Heart Attack.
- Percutaneous Coronary Intervention (PCI)
- Stable AnginaNordrehaug isAdvanced. Learn about Stable Angina.
- Experienced
- Abdominal Obesity Metabolic SyndromeNordrehaug isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- Alzheimer's DiseaseNordrehaug isExperienced. Learn about Alzheimer's Disease.
- AngioplastyNordrehaug isExperienced. Learn about Angioplasty.
- Aortic Valve ReplacementNordrehaug isExperienced. Learn about Aortic Valve Replacement.
- Aortic Valve StenosisNordrehaug isExperienced. Learn about Aortic Valve Stenosis.
- Atrial FibrillationNordrehaug isExperienced. Learn about Atrial Fibrillation.